Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intraoperative microscopic autofluorescence detection and characterization in brain tumors using stimulated Raman histology and two-photon fluorescence.
Fürtjes G, Reinecke D, von Spreckelsen N, Meißner AK, Rueß D, Timmer M, Freudiger C, Ion-Margineanu A, Khalid F, Watrinet K, Mawrin C, Chmyrov A, Goldbrunner R, Bruns O, Neuschmelting V. Fürtjes G, et al. Among authors: goldbrunner r. Front Oncol. 2023 May 10;13:1146031. doi: 10.3389/fonc.2023.1146031. eCollection 2023. Front Oncol. 2023. PMID: 37234975 Free PMC article.
Role of Decompressive Surgery in Neurologically Intact Patients with Low to Intermediate Intraspinal Metastatic Tumor Burden.
von Spreckelsen N, Ossmann J, Lenz M, Nadjiri L, Lenschow M, Telentschak S, Meyer J, Keßling J, Knöll P, Eysel P, Goldbrunner R, Perrech M, Scheyerer M, Celik E, Zarghooni K, Neuschmelting V. von Spreckelsen N, et al. Among authors: goldbrunner r. Cancers (Basel). 2023 Jan 6;15(2):385. doi: 10.3390/cancers15020385. Cancers (Basel). 2023. PMID: 36672334 Free PMC article.
Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer.
Meißner AK, Gutsche R, Galldiks N, Kocher M, Jünger ST, Eich ML, Nogova L, Araceli T, Schmidt NO, Ruge MI, Goldbrunner R, Proescholdt M, Grau S, Lohmann P. Meißner AK, et al. Among authors: goldbrunner r. J Neurooncol. 2023 Jul;163(3):597-605. doi: 10.1007/s11060-023-04367-7. Epub 2023 Jun 29. J Neurooncol. 2023. PMID: 37382806 Free PMC article.
Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas.
Youngblood MW, Erson-Omay Z, Li C, Najem H, Coșkun S, Tyrtova E, Montejo JD, Miyagishima DF, Barak T, Nishimura S, Harmancı AS, Clark VE, Duran D, Huttner A, Avşar T, Bayri Y, Schramm J, Boetto J, Peyre M, Riche M, Goldbrunner R, Amankulor N, Louvi A, Bilgüvar K, Pamir MN, Özduman K, Kilic T, Knight JR, Simon M, Horbinski C, Kalamarides M, Timmer M, Heimberger AB, Mishra-Gorur K, Moliterno J, Yasuno K, Günel M. Youngblood MW, et al. Among authors: goldbrunner r. Nat Commun. 2023 Oct 7;14(1):6279. doi: 10.1038/s41467-023-41926-y. Nat Commun. 2023. PMID: 37805627 Free PMC article.
Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.
Zeyen T, Paech D, Weller J, Schäfer N, Tzaridis T, Duffy C, Nitsch L, Schneider M, Potthoff AL, Steinbach JP, Hau P, Schlegel U, Seidel C, Krex D, Grauer O, Goldbrunner R, Zeiner PS, Tabatabai G, Galldiks N, Stummer W, Hattingen E, Glas M, Radbruch A, Herrlinger U, Schaub C. Zeyen T, et al. Among authors: goldbrunner r. J Neurooncol. 2023 Nov;165(2):387. doi: 10.1007/s11060-023-04488-z. J Neurooncol. 2023. PMID: 37921974 Free PMC article. No abstract available.
The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial.
Weller J, Zeyen T, Schäfer N, Schaub C, Potthoff AL, Steinbach JP, Hau P, Seidel C, Goldbrunner R, Tabatabai G, Vatter H, Tzaridis T, Schneider M, Herrlinger U. Weller J, et al. Among authors: goldbrunner r. J Neurooncol. 2023 Sep;164(3):749-755. doi: 10.1007/s11060-023-04470-9. Epub 2023 Oct 3. J Neurooncol. 2023. PMID: 37787906 Free PMC article.
Paradigm Shift in the Treatment of Meningiomas.
Krischek B, Goldbrunner R. Krischek B, et al. Among authors: goldbrunner r. Adv Exp Med Biol. 2023;1416:1-4. doi: 10.1007/978-3-031-29750-2_1. Adv Exp Med Biol. 2023. PMID: 37432615
Benchmarking palliative care practices in neurooncology: a german perspective.
Lawson McLean AC, Lawson McLean A, Ernst T, Forster MT, Freyschlag C, Gempt J, Goldbrunner R, Grau S, Jungk C, van Oorschot B, Rosahl SK, Wedding U, Senft C, Kamp MA; German Consortium for Excellence in Neurooncology, Palliative Care (GCE-NPC). Lawson McLean AC, et al. Among authors: goldbrunner r. J Neurooncol. 2024 May 2. doi: 10.1007/s11060-024-04674-7. Online ahead of print. J Neurooncol. 2024. PMID: 38696050
Meningioma: International Consortium on Meningiomas (ICOM) consensus review on scientific advances & treatment paradigms for clinicians, researchers, and patients.
Wang JZ, Landry AP, Raleigh DR, Sahm F, Walsh KM, Goldbrunner R, Yefet LS, Tonn JC, Gui C, Ostrom QT, Barnholtz-Sloan J, Perry A, Ellenbogen Y, Hanemann CO, Jungwirth G, Jenkinson MD, Tabatabai G, Mathiesen TI, McDermott MW, Tatagiba M, la Fougère C, Maas SLN, Galldiks N, Albert NL, Brastianos PK, Ehret F, Minniti G, Lamszus K, Ricklefs FL, Schittenhelm J, Drummond KJ, Dunn IF, Pathmanaban ON, Cohen-Gadol A, Sulman EP, Tabouret E, Le Rhun E, Mawrin C, Moliterno J, Weller M, Bi WL, Gao A, Yip S, Niyazi M; International Consortium on Meningiomas (ICOM); Aldape K, Wen PY, Short S, Preusser M, Nassiri F, Zadeh G. Wang JZ, et al. Among authors: goldbrunner r. Neuro Oncol. 2024 May 2:noae082. doi: 10.1093/neuonc/noae082. Online ahead of print. Neuro Oncol. 2024. PMID: 38695575
243 results